新疆35选7投注:Prices of cancer drugs to fall in China

By Wu Jin
0 Comment(s)Print E-mail www.z1ezw.cn, July 13, 2018
Adjust font size:

新疆彩票35选7 www.z1ezw.cn The highly rated black comedy movie, "Dying to Survive," has made the availability of cancer drugs in China a hot topic again.

In showing the desolate lives of leukemia patients, the movie, based on a true story, aroused great compassion across the nation for those who are verging on bankruptcy due to the expensive cancer drugs.

Following the premiere of the film on July 6, the Chinese government is deliberating on a policy aimed at slashing the prices of the cancer drugs by introducing regulations to mandate that provincial-level governments implement a centralized purchasing scheme.

According to an anonymous industrial insider, the newly established State Medical Insurance Administration recently convened in Shanghai, and discussed methods for lowering the still skyrocketing prices of cancer drugs despite the government's recent scrapping of import tariffs on all cancer drugs in May.

"These purchasing mechanisms focused mainly on cancer drugs are expected to further bring down the costs which have already been exempted from import tariffs," the insider said.

According to the State Medical Insurance Administration, medical insurance in China will further cover more cancer drugs, and make them more affordable through market access negotiations between the administration and multinational pharmaceutical companies.

Zeng Yixin, deputy director of the National Health Commission, announced in a press conference held on April 28 that China has divided the cancer drugs listed, or expected to be listed, in the medical insurance system into three catalogues.

According to Zeng, the drugs concerned can be dichotomized as Medicare and non-Medicare drugs. Moreover, the drugs covered by medical insurance can be further grouped by the number of their manufacturers.

Drugs produced by more than three pharmaceutical companies will undertake centralized drug bidding, while those below three will go through negotiations to agree a price. At the same time, medical insurance can also open access to non-Medicare drugs which have gone through meticulous and professional evaluations and intensive negotiations.

"We should fully utilize the huge market in China, where the substantial demand can play a key role in bringing down the price, and that is precisely what we want," Li Ling, director of the National Health and Development Research Center at Peking University, said in her interview with Economic Information Daily.

During the past few years, sales of anti-tumor drugs in China grew at an annual rate of about 20 percent and last year alone sales revenues reached 141 billion yuan (US$21.15 billion), according to statistics released by Qianzhan Industrial Research Institute, a consultancy headquartered in Beijing..

China is set to become the second largest market for anti-tumor drugs by sales volume – behind the United States.

Follow www.z1ezw.cn on Twitter and Facebook to join the conversation.
ChinaNews App Download

Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:    
    Racist, abusive and off-topic comments may be removed by the moderator.
  • 2013博鳌亚洲论坛嘉宾精彩演讲 2019-02-15
  • 保时捷首款纯电动车定名Taycan 明年下半年引入 2019-02-15
  • 单凭祝福的话和许愿的心不能够实现任何事情。 2019-02-14
  • 四部委:防控高铁新城单纯房地产化倾向 2019-02-14
  • 清热-热门标签-华商生活 2019-02-13
  • 奇秀直播2017年度盛典炫目开启 李现、小鬼邀你加入打call团 直播 奇秀 2019-02-12
  • 国际责任不是“负担” 一些西方国家为何理解不了? 2019-02-12
  • 科技赋能助力医保革新,平安开启商保服务新模式 2019-02-11
  • 中国足球,就是笑博士的“责权利平滑对接”改革的必然结果! 2019-02-10
  • 【理上网来·辉煌十九大】意大利各界关注十九大:中国共产党将把"保障人民幸福"作为其重要使命 2019-02-10
  • 动物园里迎端午 大熊猫爬上爬下吃“粽子” 2019-02-09
  • 王勇:提升全民安全素质 夯实安全发展基础 2019-02-09
  • 摇碎一湖金:迷失相机里 如何读懂西湖之美? 2019-02-08
  • 力度空前!个税起征点提高至每月5000元!还有这些消息与你的钱包有关 2019-02-08
  • 泸州老窖股份有限公司获第十二届人民企业社会责任奖年度扶贫奖 2019-02-07
  • 831| 782| 542| 941| 355| 189| 570| 405| 354| 379|